Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. - Wikidata - wikimedia - TriplyDB

Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

http://www.wikidata.org/entity/Q44093885

about

Muscle relaxants versus placebo for tension-type headache prophylaxis Muscle relaxants versus placebo for tension-type headache prophylaxis Italian guidelines for primary headaches: 2012 revised version A rational approach to the management of chronic migraine.The prophylactic treatment of chronic daily headache.Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.New developments in migraine prophylaxis.Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily Headache General principles of migraine management: the changing role of prevention.Management of chronic daily headache: challenges in clinical practice.Chronic daily headaches.Clinical management of pain in advanced lung cancer.Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial.Botulinum toxin type A for the treatment of migraine.Pharmacotherapy of tension-type headache (TTH).Current and emerging treatment options for migraine and other primary headache disorders.Treatment of chronic overmedicated headache patients.Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot study Tackling chronic migraine: current perspectives.The Face of Chronic Migraine Which Has Started to be Clarified.Treatment of chronic migraine.Pediatric headache: a clinical review.Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine.Outcome of Chronic Daily Headache or Chronic Migraine.Update on the Pharmacological Treatment of Chronic Migraine.Chronic Daily Headache: Mechanisms and Principles of Management.Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.Chronic migraine: risk factors, mechanisms and treatment.Treatment Update of Chronic Migraine.Production and stability evaluation of modified-release microparticles for the delivery of drug combinations.Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.Tizanidine is not a cure for chronic daily headache.[Chronic migraine].Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.Predictors of a negative response to topiramate therapy in patients with chronic migraine.Biofeedback therapy for pediatric headache: factors associated with response.Botox therapy for refractory chronic migraine.

P2860

Q24234554-A58EB5B0-C879-44F8-BF30-28D7271B6987 Q24240876-1774DDAC-C9F1-421B-8BC4-0552FE7E1B99 Q30466790-AEBE2D8C-C787-46C2-99AB-D9567FC29033 Q34321114-83172569-1D74-4ECD-A73C-CB50BF178254 Q34583067-E29CA903-931A-4D26-9D07-B9A6EE95E8AB Q34619560-CC9EB481-1CF5-4EBD-A618-B4B2C2A79CE2 Q35095175-544F0298-C63D-4B44-9B33-E196D83F0B74 Q35680421-FE19B4D9-3183-4E78-BF27-473DC751E6B3 Q35690766-2319CC19-0817-4C23-9754-C3E9C4F2ABA7 Q35697916-3DCDC986-37AA-4C63-A3BA-DA86E7376962 Q36099512-EAD73C58-1F6E-4E0C-9087-61B313B71649 Q36099528-FC0A2926-D276-43F3-A915-16D4A7F22113 Q36239475-5D02A9DD-EC05-4D22-AB8B-0F1297DA884D Q36327481-9D010A06-7249-4D6B-8453-79ED1457059C Q36332465-C639042F-45CC-4379-9F8B-AFCC96E99D30 Q36488226-24F95970-800E-4996-9694-481D49702847 Q37492582-CD0D70B2-5CBC-47A9-A94C-8E23DBB21372 Q37610198-365B8610-B6BF-4531-BBED-314D2007E604 Q37610200-B948D8F0-1E7F-4983-B8C7-6C447FB8D458 Q37661031-53D634A5-BC33-4BF0-ABC2-09D483AC397C Q37702228-A91B5F3E-CC1C-4BE6-9887-2DE604871BB5 Q37703839-F270A946-9336-40B3-94D7-A337D0A88E64 Q37809775-1899085A-F8B3-48B1-81AA-C1BA5B776B37 Q37979834-9D804B8E-BC41-46E9-B44C-F2104F3F7A71 Q38255772-5336D362-7740-4081-9B68-BEDA92E15608 Q38569170-8108DBE2-12AF-4CB4-B834-999F801A3171 Q38676484-A53220FB-6FB3-4174-AA6A-13B2B376FD3A Q38686130-2BC10598-CD54-4022-A57F-0B39C992185B Q38700966-A9ED3CF2-030B-4B56-864B-42878A7DD31F Q38773592-114FB3A5-23E0-4621-A2DC-C5F7E8DE6DEF Q38889450-BBBB7840-EC35-4A50-8BD0-5FFD9D7C4F0E Q39251409-20D1E3B5-509B-4252-ADCF-4AEE66E523F7 Q39923159-B5F241C7-B997-4379-8DE0-0F7C2F4FF42C Q42653763-9B6942E7-B6B1-4856-9D93-2EF793EE5094 Q44326438-4BD6DB53-EFD6-4998-B3B7-A0327C3A57D6 Q44588435-F300C2C8-0DEE-4C90-A621-A88CA6746A04 Q46442389-0875C845-C93D-4A7B-836E-02A3C64871CE Q46572343-3C2629D3-BB91-4471-85C1-CA6FD7F90325 Q46827382-E1DDB1B4-C012-4045-A339-15800F5DDE9A Q53860656-A1A40F17-B314-4002-9648-A481BC5A914E

P2860

Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

http://www.wikidata.org/entity/Q44093885

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Chronic daily headache prophyl ...... ed, multicenter outcome study.

@en

Chronic daily headache prophyl ...... ed, multicenter outcome study.

@nl

type

label

Chronic daily headache prophyl ...... ed, multicenter outcome study.

@en

Chronic daily headache prophyl ...... ed, multicenter outcome study.

@nl

prefLabel

Chronic daily headache prophyl ...... ed, multicenter outcome study.

@en

Chronic daily headache prophyl ...... ed, multicenter outcome study.

@nl

P1433

Q44093885-C295CC07-1241-4085-8AD0-322FC945B321

P1476

Q44093885-36141B24-4ADD-4D05-BEED-7921872501FB

P2093

Q44093885-10449E5E-D50B-4A82-86D8-9A42AB2B7F65

Q44093885-5DD1ED2C-B4B8-44C8-A162-23412310DDB2

Q44093885-87ED3E06-0829-46F8-9B96-ECA3FDC61932

Q44093885-CB811D4C-CA38-48B5-BEAC-6262D801CD7D

Q44093885-E8E029C7-DEA7-44EF-B4A0-A10C7E41242D

P2860

Q44093885-08011270-AB90-4BF3-AFDA-C3F24BACA953

Q44093885-0D53988D-655E-4368-8952-AABAD8BEAAA5

Q44093885-1268BA13-2C49-4D4B-A015-FDDE24D0F7FE

Q44093885-1BEC618A-BFF9-4CDD-92DB-371D88E5D4C6

Q44093885-1EC876F5-6B01-4DDC-A958-B0E7DFD3A05B

Q44093885-21B8EC15-E100-4D85-A5F5-40BEA6FC2117

Q44093885-41F97BF8-01B7-46BB-ADD7-E6C6FABEEEA6

Q44093885-49A6F49D-0FFD-43C3-8CBA-E4C3A59F17F0

Q44093885-4F1D0F2A-6F6C-4E83-8A6D-E5EC9A7688E8

Q44093885-518FF284-B955-466F-95D6-9608DB9357A7

P304

Q44093885-C31EB3F4-F3E4-4823-9645-E4FCDDB31D41

P31

Q44093885-91EBB357-CF4B-4D61-B491-D8FB65184B3D

P356

Q44093885-AC131398-5FDA-4336-8078-EC9E75266A01

P433

Q44093885-2D90FB21-3AB4-4AF1-BEEF-88304F5A4998

P478

Q44093885-E8E712F2-6483-4FC3-B68A-6FECF2E2416F

P577

Q44093885-F80B89E0-B4A2-4DE9-A661-8915FD14ED98

P698

Q44093885-0EFA997B-B15B-42D8-B547-29D293D32735

P921

Q44093885-21DF2AF4-FD0E-4FBD-8918-388F1AA607C5

Q44093885-F52A0F4F-5583-4890-98EF-40F4326BDE40

P356

J.1526-4610.2002.02122.X

P1433

P1476

Chronic daily headache prophyl ...... ed, multicenter outcome study.

@en

P2093

Alvin E Lake

http://www.w3.org/2001/XMLSchema#string

Deborah T Cantrell

http://www.w3.org/2001/XMLSchema#string

Jeffery R White

http://www.w3.org/2001/XMLSchema#string

Joel R Saper

http://www.w3.org/2001/XMLSchema#string

Paul K Winner

http://www.w3.org/2001/XMLSchema#string

P2860

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial

Prophylactic pharmacological treatment of chronic daily headache.

Multispecialty consensus on diagnosis and treatment of headache.

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.

Deconstructing migraine headache into peripheral and central sensitization.

Brain stem activation in spontaneous human migraine attacks.

Behavioral and nonpharmacologic treatments of headache.

A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache

Transformed migraine, analgesic rebound, and other chronic daily headaches.

P304

470-482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1526-4610.2002.02122.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12167135

http://www.w3.org/2001/XMLSchema#string

P921